Trial intelligence / Profile preview

ASA and omeprazole pharmacokinetics before and after Roux-en-Y gastric bypass

NL-OMON26757Recruiting

Sponsor
Haaglanden Medisch Centrum Department of Hospital Pharmacy
Start
May 2013
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of aspirin and omeprazole in class III obesity, sponsored by Haaglanden Medisch Centrum Department of Hospital Pharmacy. Primary endpoints: Time to peak concentration of salicylic acid, Peak concentration of salicylic acid and 7 more. Started May 2013; status: recruiting.

02

Drugs

aspirinomeprazole
03

Conditions

class III obesity

Beyond the preview

Go deeper on NL-OMON26757.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26757.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call